Adage Capital Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $180M | Buy |
|
|||||
|
2023
Q1 | $42.7M | Sell |
|
|||||
|
2022
Q4 | $49.6M | Buy |
|
|||||
|
2022
Q3 | $6.03M | Sell |
|
|||||
|
2022
Q2 | $31.1M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.71M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $11.5M | Sell |
|
|||||
|
2019
Q4 | $23.1M | Buy |
|
|||||
|
2019
Q3 | $7.63M | Buy |
|
|||||
|
2019
Q2 | $4.25M | Buy |
|